BioCentriq® Launches LEAP™ Advanced Therapy Platform with Proven Assets and Expertise that Help Early-Stage BioTech Companies Reach Patients in Record Time

Proprietary Platform Moves Promising Cell Therapy Candidates from Contract to Clinic in Six Months NEWARK, N.J., June 1, 2023 /PRNewswire/ — BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy launched their new LEAP™ Advanced Therapy Platform today at the 29th International Society for Cell & Gene Therapy (ISCT) annual event. LEAP™ Platform … Read more

CANTEX PHARMACEUTICALS OBTAINS EXCLUSIVE WORLDWIDE RIGHTS TO INTELLECTUAL PROPERTY FROM GEORGETOWN UNIVERSITY FOR AZELIRAGON AS A POTENTIAL TREATMENT OF CANCER-RELATED COGNITIVE DECLINE

Cantex to Expand Collaboration with Georgetown’s Lombardi Comprehensive Cancer Center WESTON, Fla., June 1, 2023 /PRNewswire/ — Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, today announced that it has obtained an exclusive worldwide license from Georgetown University … Read more

Petco Unveils Complete Pet Care Experience at New Flagship in New York City

Petco’s new two-story, 25,000 square-foot flagship pet care center combines the best of Petco’s physical and digital offerings, including a stylish grooming salon, full-service veterinary hospital, JustFoodForDogs kitchen, curated merchandise assortment and more for a complete pet care experience. “We’re delighted to welcome pets and pet parents to this revolutionary flagship experience that embodies Petco’s fully … Read more

Cano Health Highlights Long-Term Value Creation Strategy in New Investor Presentation

Draws a sharp contrast between the Board and management’s clear long-term stockholder value creation plan and the former directors’ short-term, self-interested agenda Urges stockholders to vote on the WHITE proxy card “FOR” re-election of the Company’s directors and the proposed reverse stock split MIAMI, May 31, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or … Read more

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT THE 44th ANNUAL GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE

KING OF PRUSSIA, Pa., May 31, 2023 /PRNewswire/ — Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at the 44th Annual Goldman Sachs Global Healthcare Conference on Monday, June 12, 2023, at 4:40pm (PT)/7:40pm (ET). A live audio webcast … Read more

HEALTHCARE TRUST INC. COMPLETES $240 MILLION LOAN

NEW YORK, May 31, 2023 /PRNewswire/ — Healthcare Trust, Inc. (Nasdaq: HTIA / HTIBP) (“HTI” or “the Company”) announced today that, through its subsidiaries, the Company completed a $240 million commercial mortgage-backed security loan (the “Loan”) encumbered by 62 medical office buildings (“MOB”) across the United States. The Loan has a 10-year term and is … Read more

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

TORRANCE, Calif., May 31, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration Certificate (DRN-10164/23) from the Bahrain National Health Regulatory Authority (NHRA) granting marketing authorization for the commercial distribution and sale of Endari® in the Kingdom of Bahrain.   Endari® … Read more

Omega Laboratories Achieves ISO 17025 Accreditation at Ontario, Canada Laboratory

MOGADORE, Ohio, May 31, 2023 /PRNewswire/ — Omega Laboratories (“Omega”), a leading provider of laboratory testing solutions, is proud to announce that its toxicology laboratory in Ontario, Canada, has been awarded ISO 17025 accreditation. This significant achievement highlights Omega Laboratories’ commitment to maintaining the highest standards of quality and precision in its operations. ISO/IEC 17025 … Read more

Blue Lake Biotechnology to Be Featured at the Biotechnology Innovation Organization (BIO) International Convention

ATHENS, Ga. and LOS GATOS, Calif., May 31, 2023 /PRNewswire/ — Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to protect against serious infectious diseases, announced today that company CEO Biao He, Ph.D., will present and host one-on-one partnering meetings at the 2023 Biotechnology Innovation Organization International … Read more

VESTECK CONTINUES TO HELP PATIENTS AROUND THE WORLD

WEST CHESTER, Pa., May 31, 2023 /PRNewswire/ — VESTECK, Inc. is excited to announce the successful completion of 7 Endovascular Aortic Repair (EVAR) clinical cases with the “SUTURE-TIGHT”™ device. Professor Dainis Krievins and Dr. Bao Bui, performed the 2 most recent EVAR procedures in Riga, Latvia, suturing EVAR grafts to the aorta with the “SUTURE-TIGHT”™ … Read more